naturelover
11-25-2009, 05:34 PM
The University of Alabama at Birmingham (UAB) is spearheading an effort to create a national database and repository to enable researchers to identify predictors of effectiveness of various treatments for rheumatoid arthritis (RA).
A two-year, $3.3 million Grand Opportunity (GO) grant from the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (NIAMS) and funds from the national office and the Alabama chapter of the Arthritis Foundation will establish the Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository (TETRAD).
Led by UAB with 10 participating sites, TETRAD will create a large, sustainable database of treatment-response data and a repository of accompanying samples of DNA and blood cells from RA patients starting treatment with different drugs.
I just got this data from online and think if all proceeds well will ultimately not only going to cut the number of medicines RA has to take, butreduce the cost of medicines too.
A two-year, $3.3 million Grand Opportunity (GO) grant from the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (NIAMS) and funds from the national office and the Alabama chapter of the Arthritis Foundation will establish the Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository (TETRAD).
Led by UAB with 10 participating sites, TETRAD will create a large, sustainable database of treatment-response data and a repository of accompanying samples of DNA and blood cells from RA patients starting treatment with different drugs.
I just got this data from online and think if all proceeds well will ultimately not only going to cut the number of medicines RA has to take, butreduce the cost of medicines too.